佛慈制药
(002644)
| 流通市值：39.98亿 | | | 总市值：39.98亿 |
| 流通股本：5.11亿 | | | 总股本：5.11亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 386,336,618.95 | 397,893,224.19 | 351,622,449.61 | 362,369,100.93 |
| 应收票据及应收账款 | 365,285,040.98 | 376,688,186.67 | 343,973,094.8 | 327,882,275.47 |
| 其中：应收票据 | 39,110,167.82 | 68,049,181.58 | - | - |
| 应收账款 | 326,174,873.16 | 308,639,005.09 | 343,973,094.8 | 327,882,275.47 |
| 应收款项融资 | 51,667,856.51 | 36,884,461.7 | 45,395,807.46 | 29,664,020.67 |
| 预付款项 | 7,273,820.62 | 9,530,840.22 | 16,980,207.27 | 17,218,331.12 |
| 其他应收款合计 | 26,048,029.3 | 32,205,213.98 | 37,249,690.65 | 36,081,145.12 |
| 存货 | 313,464,384.14 | 339,991,996.73 | 405,498,888.06 | 418,135,714.66 |
| 其他流动资产 | 28,852,060.56 | 28,690,157.97 | 25,861,114.36 | 25,927,552.66 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,178,927,811.06 | 1,221,884,081.46 | 1,226,581,252.21 | 1,217,278,140.63 |
| 非流动资产: | | | | |
| 长期股权投资 | 54,501,844.05 | 55,663,345.27 | 57,546,825.06 | 60,656,787.9 |
| 投资性房地产 | 7,619,337.48 | 7,305,898.21 | 7,803,812.61 | 7,908,166.23 |
| 固定资产 | 1,024,892,594.2 | 1,028,543,483.45 | 1,021,858,630.11 | 1,039,106,917.53 |
| 在建工程 | 1,764,636.34 | 1,764,636.34 | 3,789,261.28 | 2,626,417.24 |
| 使用权资产 | 1,528,226.61 | 1,703,185.51 | 1,597,488.33 | 1,903,626.45 |
| 无形资产 | 76,065,226.84 | 76,866,361.82 | 77,653,093.2 | 78,552,506.17 |
| 商誉 | 9,009,586.84 | 9,009,586.84 | 9,009,586.84 | 9,009,586.84 |
| 长期待摊费用 | 1,627,816.5 | 3,756,694.1 | 5,981,476.88 | 5,492,213.94 |
| 递延所得税资产 | 62,863,496.66 | 61,809,926.77 | 53,832,447.09 | 55,772,493.32 |
| 其他非流动资产 | 1,970,908.3 | 1,478,108.3 | 5,931,102.7 | 6,114,238.27 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,241,843,673.82 | 1,247,901,226.61 | 1,245,003,724.1 | 1,267,142,953.89 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,420,771,484.88 | 2,469,785,308.07 | 2,471,584,976.31 | 2,484,421,094.52 |
| 流动负债: | | | | |
| 短期借款 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 |
| 应付票据及应付账款 | 191,734,965.35 | 213,094,120.68 | 261,503,730.93 | 297,117,035.49 |
| 其中：应付票据 | - | 5,172,114.56 | 5,172,114.56 | - |
| 应付账款 | 191,734,965.35 | 207,922,006.12 | 256,331,616.37 | 297,117,035.49 |
| 合同负债 | 24,943,542.25 | 16,047,074.96 | 28,071,729.93 | 31,181,370.87 |
| 应付职工薪酬 | 1,359,657.53 | 2,074,341.56 | 3,029,454 | 3,078,574 |
| 应交税费 | 31,738,139.66 | 27,616,187.15 | 23,682,905.38 | 19,524,088.42 |
| 其他应付款合计 | 39,293,071.77 | 47,898,581.98 | 64,395,548.97 | 40,997,711.32 |
| 一年内到期的非流动负债 | 13,440,758.33 | 14,742,375.4 | 14,861,168.66 | 14,073,467.71 |
| 其他流动负债 | 12,277,738.09 | 48,255,999.88 | 3,662,344.8 | 3,691,521.82 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 324,787,872.98 | 379,728,681.61 | 409,206,882.67 | 419,663,769.63 |
| 非流动负债: | | | | |
| 长期借款 | 3,800,000 | 1,800,000 | - | - |
| 租赁负债 | 1,226,399.12 | 1,049,303.61 | 1,354,973.17 | 1,459,793.1 |
| 长期应付款 | - | 13,200,000 | 13,200,000 | 13,200,000 |
| 递延收益 | 252,485,995.22 | 256,096,626.91 | 251,894,755.27 | 256,584,553.63 |
| 递延所得税负债 | 3,365,429.36 | 2,931,262.53 | 1,965,378.07 | 2,842,524 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 260,877,823.7 | 275,077,193.05 | 268,415,106.51 | 274,086,870.73 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 585,665,696.68 | 654,805,874.66 | 677,621,989.18 | 693,750,640.36 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 510,657,000 | 510,657,000 | 510,657,000 | 510,657,000 |
| 资本公积 | 337,393,806.93 | 337,393,806.93 | 337,378,624.27 | 337,378,624.27 |
| 其他综合收益 | 9,689.99 | 9,689.99 | 192,780.92 | 197,205.55 |
| 专项储备 | 952,250.19 | 952,250.19 | 1,134,763.8 | 1,268,476.58 |
| 盈余公积 | 126,006,345.3 | 126,006,345.3 | 119,928,027.47 | 119,928,027.47 |
| 未分配利润 | 834,252,962.53 | 814,869,202.34 | 799,950,645.14 | 796,972,982.3 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,809,272,054.94 | 1,789,888,294.75 | 1,769,241,841.6 | 1,766,402,316.17 |
| 少数股东权益 | 25,833,733.26 | 25,091,138.66 | 24,721,145.53 | 24,268,137.99 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,835,105,788.2 | 1,814,979,433.41 | 1,793,962,987.13 | 1,790,670,454.16 |
| 负债和股东权益合计 | 2,420,771,484.88 | 2,469,785,308.07 | 2,471,584,976.31 | 2,484,421,094.52 |
| 公告日期 | 2025-04-26 | 2025-04-26 | 2024-10-26 | 2024-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |